Ambev S.A.
3.30USD
-0.0300 (-0.90%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ABEV.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.05▼ | $0.05 | 1 | 0 |
| Next quarter | $0.06▼ | $0.06 | 0 | 2 |
| Current year | $0.2▲ | $0.2 | 2 | 1 |
| Next year | $0.21▼ | $0.22 | 3 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.03 | $0.04 | +0.01 (+24.9%) |
| 2026-03-31 | $0.04 | $0.05 | +0.01 (+14.0%) |
| 2025-12-31 | $0.05 | $0.05 | -0.00 (-0.9%) |
| 2025-09-30 | $0.04 | $0.04 | +0.00 (+9.6%) |
53 ratings from 14 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| B of A Securities | Downgraded from Neutral | Underperform | $3.3 | Oct 7, 2026 |
| Scotiabank | Downgraded from Sector Outperform | Sector Perform | — | Jul 15, 2026 |
| UBS | Maintained | Sell | $2.65 $2.9 | May 14, 2026 |
| Barclays | Maintained | Equal-Weight | $3 $3.5 | May 6, 2026 |
| UBS | Downgraded from Neutral | Sell | — | Apr 16, 2026 |
| Barclays | Maintained | Equal-Weight | $2.5 $3 | Feb 17, 2026 |
| Bernstein | Downgraded from Outperform | Market Perform | $2.88 | Nov 26, 2025 |
| UBS | Maintained | Neutral | $2.5 $2.2 | Aug 20, 2025 |
| HSBC | Downgraded from Buy | Hold | — | Aug 1, 2025 |
| UBS | Maintained | Neutral | $2.6 $2.7 | Jun 4, 2025 |
| Barclays | Maintained | Equal-Weight | $2 $2.5 | May 12, 2025 |
| UBS | Downgraded from Buy | Neutral | — | Apr 22, 2025 |
| Morgan Stanley | Downgraded from Equal-Weight | Underweight | — | Apr 7, 2025 |
| UBS | Maintained | Buy | $2.9 $2.6 | Mar 5, 2025 |
| Citigroup | Downgraded from Buy | Neutral | — | Jan 22, 2025 |
| Barclays | Maintained | Equal-Weight | $2.5 $2 | Jan 21, 2025 |
| UBS | Maintained | Buy | $3.2 $2.9 | Jul 31, 2024 |
| Barclays | Maintained | Equal-Weight | $3 $2.5 | May 9, 2024 |
| Barclays | Downgraded from Overweight | Equal-Weight | $3.5 $3 | Mar 4, 2024 |
| Jefferies | Initiated | Hold | $2.86 | Nov 22, 2023 |
| Bernstein | Initiated | Outperform | $3.74 | May 24, 2023 |
| JP Morgan | Upgraded from Neutral | Overweight | — | Jul 13, 2022 |
| B of A Securities | Upgraded from Underperform | Neutral | — | Nov 3, 2021 |
| Barclays | Upgraded from Equal-Weight | Overweight | $4 $3.5 | Oct 6, 2021 |
| Barclays | Upgraded from Underweight | Equal-Weight | $2.5 $4 | Jun 17, 2021 |
1 filing from 1 insider · 0 buy / 0 sell over 6m
Officers and directors of ABEV, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Crippa Prado Carla Smith de VasconcellosOfficer, See Remarks | Sell | 60.8k | $3.09 | $188k | Sep 3, 2026 |
No analyst notes on ABEV yet.
Members whose judged calls on ABEV have played out most reliably.
No settled calls on ABEV yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 1 | 5 | 2 | 1 | Hold2.91 |
| 1 mo ago | 2 | 1 | 6 | 2 | 0 | Hold2.73 |
| 2 mo ago | 2 | 1 | 6 | 2 | 0 | Hold2.73 |
| 3 mo ago | 2 | 1 | 6 | 2 | 0 | Hold2.73 |